Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer

Clinical trial NCT02713529 · COMPLETED

Trial details

NCT number: NCT02713529
Sponsor: AmMax Bio, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer Colorectal Cancer Non-Small Cell Lung Cancer

Start date: 2016-04-14
Primary completion: 2019-01-02
Enrollment: 117

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.